Questions Circle INDs; Industry Needs Guidance For Probiotics, Say Experts

FDA should consider issuing a guidance for probiotics similar to the 2004 industry guidance for botanical drugs, panelists said at a recent Drug Information Association conference

More from Archive

More from Pink Sheet